Ajanta House

T +91 22 6606 1000

Charkop, Kandivli West,

F +91 22 6606 1200

Mumbai 400 067

E info@ajantapharma.com

India

W www.ajantapharma.com

4th July 2022

BSE LIMITED

National Stock Exchange of India,

Phiroze Jeejeebhoy Towers

Exchange Plaza, 5th Floor, Plot no.

Dalal Street,

C/1, G Block, Bandra Kurla Complex,

Mumbai - 400001

Bandra (East), Mumbai - 400 051

Scrip Code: BSE - AJANTPHARM 532331

Scrip Code: NSE AJANTPHARM EQ

Sub.: Compliance Under Regulation 47 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

Dear Sir/Madam,

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed notice published in newspapers in terms of Circular No. 20/2020 dated 5th May 2020 issued by Ministry of Corporate Affairs, inter-alia, intimating that 43rd Annual General Meeting of the Company will be held on 4th August 2022 through Video Conferencing/Other Audio-Visual Means, in the following newspapers on 2nd July 2022:

  1. Mumbai edition of Economic Times;
  2. Mumbai edition of Navshakti.

Please take in on your record.

Yours faithfully,

GAURANG

Digitally signed by

GAURANG

CHINUBHAI CHINUBHAI SHAH

SHAH

Date: 2022.07.04

08:22:24 +05'30'

GAURANG SHAH

VP - Legal & Company Secretary

Encl.: a/a

Corporate Identity Number - L24230MH1979PLC022059

14

e{Zdma, 2

2022

Continue from previous page....

PROFIT & LOSS APPROPRIATION ACCOUNT FOR THE YEAR ENDED 31st MARCH 2022

For the year ended

EXPENDITURE

For the year ended

For the year ended

INCOME

For the year ended

31st MARCH 2021

31st MARCH 2022

31ST MARCH 2021

31st MARCH 2022

Rs.

Ps.

Rs.

Ps. Rs.

Ps. Rs.

Ps.

Rs.

Ps. Rs.

Ps.

Appropriations subject to Approval in AGM

72,10,32,289.29 Net Profit Brought Forward

74,40,24,347.57

- Profit of last year

4,50,53,497.35

18,02,58,072.32

Statutory Reserve Fund

18,60,06,086.89

7,21,03,228.93

Contigency Reserve Fund

7,44,02,434.76

1,73,31,000.00 Transfer from revaluation reserve

1,73,31,000.00

5,00,00,000.00

Investment Fluctuation Reserve

6,00,00,000.00

15,00,000.00

Death Benefit Fund

15,00,000.00

-

Charity Fund

74,40,243.48

1,44,20,645.79

Members Welfare Fund

5,24,93,740.48

19,62,944.25

General reserve

3,12,47,514.32

-

Staff Welfare Fund

5,00,000.00

20,00,000.00

Election Fund

-

28,10,00,000.00

Bad and Doubtful Debt Fund

25,00,00,000.00

60,32,44,891.29

66,35,90,019.92

13,51,18,398.00

NET PROFIT CARRIED TO BALANCE SHEET

14,28,18,825.00

73,83,63,289.29

TOTAL

80,64,08,844.92

73,83,63,289.29

80,64,08,844.92

As per our report of even date attached

For Batliboi & Purohit

Chartered Accountants

Firm Regn.No.101048W

CA Raman Hangekar

Sd/-

Sd/-

Sd/-

Sd/-

Partner

Ryan Fernandes

Simon Soares

Domnic D'mello

Sixto Fargose

Membership .No.- 030615

Chairman

Vice - Chairman

Director

Acting CEO

Place - Papdy, Vasai

Date - 30.06.2022

INDEPENDENT AUDITORS' REPORT

The Members,

Bassein Catholic Co-Op. Bank Ltd.

Papdy, Vasai, Dist. Palghar-401 207.

Report on Audit of the Financial Statements

Qualified Opinion

  1. We have audited the accompanying Financial Statements of "Bassein Catholic Co-Operative Bank Limited" (hereinafter referred to as 'the Bank'), as at 31st March, 2022, which comprise the Balance Sheet as at 31st March, 2022 and Profit and Loss Account, and the Cash Flow Statement for the year then ended and a summary of significant accounting policies and other explanatory information. The returns of Head Office and its departments and 15 branches (including Treasury & Forex Branch) visited by us during audit and the returns of 48 branches and 1 extension counter which have been certified by the branch management and independently reviewed by the concurrent/ internal auditors of the respective branches are incorporated in these financial statements.
  2. In our opinion and to the best of our information and according to the explanations given to us except for the effects of the matter described in the "Basis for Qualified Opinion" section of our report and our detailed observations mentioned in the Audit Memorandum, the aforesaid financial statements read together with the Notes, give the information required thereon by the Banking Regulation Act, 1949 as well as Maharashtra Co-operativeSocieties Act, 1960 and rules made there under, in the manner so required, for the Urban Co-operativeBanks, guidelines issued by Reserve Bank of India and the Registrar of Co- operative Societies, in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India:
    1. In the case of the Balance Sheet, of state of affairs of the Bank as at 31st March, 2022.
    2. In the case of the Profit and Loss Account, of the profit for the year ended on that date and
    3. In the case of the Cash Flow Statement, of the cash flows for the year ended on that date.

Basis for Qualified Opinion

  1. We draw attention to Note No. 19 of Notes forming part of accounts regarding upgradation of 183 NPA borrower accounts by considering the post Balance Sheet date recoveries in these accounts. Due to the upgradation of these NPA accounts to Standard Category based on post Balance Sheet date recoveries, NPA is reduced by Rs. 1679.56 Lakhs resulting into reduction of Gross and Net NPA by 0.40% & 0.12% respectively. The Bank has not accrued the interest income towards this upgradation and also has excess provision in respect of NPA.
  2. We draw attention to Note No. 33 of Notes forming part of accounts regarding settlement of 233 accounts under One Time Settlement scheme other than Government scheme having Total outstanding balance of Rs. 25,25,11,633/- of which Rs. 21,24,97,041/- has been recovered and burden to the Bank of Rs. 3,86,11,092/- has been written off. There is no Board approved policy regarding OTS scheme but all these cases were recommended by the respective Branches and approved in Recovery Committee meeting and Board of Directors.
  3. We draw attention to Note No. 34 of Notes forming part of accounts which states that the OMNI CBS system is not calculating the interest and commission on BG, LC's and Bills Discounted and the same is being done manually by the branches. Forex transactions are not integrated in the OMNI CBS system and the branches are manually entering these transactions in the system. Also, BG's are being issued manually instead from the OMNI CBS system.
  4. We draw attention to Note No. 35 of Notes forming part of accounts regarding certain deficiencies in the OMNI CBS system which are under the process of rectification such as identification and classification of

NPAs, appropriation of recoveries in NPAs, wrong interest income booking in NPAs, Provisioning done manually on NPAs etc. The net impact on the profit and advances is not ascertainable but the Management is of the opinion that the said impact would not be material.

We conducted our audit in accordance with the Standards on Auditing (SAs) issued by the Institute of Chartered Accountants of India (ICAI). Our responsibilities under those Standards are further described in the Auditors Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Bank in accordance with the code of ethics issued by the Institute of Chartered Accountants of India together with ethical requirements that are relevant to our audit of the Financial Statements under the provision of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the code of ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of Matter

7. We draw attention to Note no. 31 of Notes forming part of the accounts which describes uncertainty of impact due to Covid-19 pandemic on Bank's financial performance, which continues to be uncertain and as such, it is difficult to predict time horizons to gauge the impact thereof & is dependent on future development.

Our opinion is not modified in respect of these matters.

Responsibilities of Management and Those Charged with Governance for the Financial Statement

8. The Bank's Board of Directors is responsible for the preparation of these Financial Statements that give a true and fair view of the financial position, financial performance and cash flows of the Bank in accordance with accounting principles generally accepted in India, including the Accounting Standards issued by ICAI, The Banking Regulation Act,1949 (as applicable to Co-operative Societies), the guidelines issued by Reserve Bank of India and the Registrar of Co-operative Societies, Maharashtra, The Maharashtra Co-operative Societies Act, 1960 & rules made thereunder. This responsibility also includes maintenance of adequate records in accordance with the provisions of the Act for safeguarding of assets of the Bank and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgements and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Financial Statements that give true and fair view and are free from material misstatement, whether due to fraud or error. In preparing the Financial Statements, management is responsible for assessing the Bank's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Bank or to cease operations, or has no realistic alternative but to do so. Those Board of Directors are also responsible for

overseeing the Bank's financial reporting process.

Auditors' Responsibility for the Audit of Financial Statements

9. Our objectives are to obtain reasonable assurance about whether the Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Financial Statements. As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  • Identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls.
  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
  • Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the bank's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors' report to the related disclosures in the Financial Statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors' report. However, future events or conditions may cause the bank to cease to continue as a going concern.
  • Evaluate the overall presentation, structure and content of the Financial Statements, including the disclosures, and whether the Financial Statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards. From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the Financial Statements of the current period and are therefore the key audit matters. We describe these matters

in our auditors' report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Other Matters

10. In view of the spreading of COVID19 across India, we were unable to physically visit some of the branches to undertake audit procedures prescribed under ICAI issued standards on Auditing in regard to certain aspects of the year-end statutory audit, including but not limited to:

  • Physical verification of Cash in Hand & Cash at ATM on the year end.
  • Physical verification of gold/stationery items including adequate internal controls thereof on the year end.

We have relied on alternative audit procedures as per the SAs to obtain reasonable assurance whether the Financial Statements, as a whole, are free from material misstatement, whether due to fraud or error. Our opinion is not modified in respect of this matters.

Report on Other Legal and Regulatory Requirements

The Balance Sheet and the Profit and Loss Account have been drawn up in Forms "A" and "B" respectively of the Third Schedule to the Banking Regulation Act, 1949 and provisions of the Maharashtra Co-operative Societies Act, 1960 and the Maharashtra Co-operative Societies Rules,1961.

We report that:

  1. We have obtained all the information and explanations, which to the best of our knowledge and belief were necessary for the purpose of our audit and have found to be satisfactory;
  2. In our opinion, proper books of accounts as required by law have been kept by the Bank so far as it appears from our examination of those books and proper returns adequate for the purposes of our audit have been received from the branches/offices;
  3. The transactions of the Bank which have come to our notice are within the powers of the Bank;
  4. The Balance Sheet and the Profit and Loss Account and the Cash Flow dealt with by this report, are in agreement with the books of account and the returns;
  5. The accounting standards adopted by the Bank are consistent with those laid down by accounting principles generally accepted in India so far as applicable to banks.

As required by the Rule 69 (6) of the Maharashtra Co-operative Societies Rules, 1961, we report on the matters specified in clauses (i) to (iv) of the said Rule to the extent applicable to the Bank-

  1. During the course of our audit, we have generally not come across transactions which appear to be contrary to the provisions of the Act, the Rules or the Bye-Laws of the Bank.
  2. During the course of our audit, we have generally not come across any sums which ought to have been but have not been brought into account by the Bank.
  3. Following monies due to the Bank appear to be doubtful of recovery against which a provision of Rs. 20521.13 Lakhs is made in the accounts. Advances categorized as doubtful and loss assets as per Prudential Norms are considered as doubtful of recovery:

Category

Outstanding as on 31.03.2022

(Rs. In Lakhs)

Doubtful Assets

33642.16

Loss Assets

776.87

Total

34419.03

Adequate provision has been made against the above advances as per RBI guidelines.

  1. To the best of our knowledge, no other matters have been specified by the Registrar, which require reporting under this Rule. We further report that for the year 2020-22 under audit, the Bank has been awarded "A" classification.

For Batliboi & Purohit,

Chartered Accountants

Firm Reg. No.101048W

(CA Raman Hangekar)

Partner

M. No. 030615

Place: Papdy, Vasai

Date: 30.06.2022

UDIN: 22030615ALZKMG3377

A{YH$mar

ݶm¶m{YH$aU,

(S>rAmaQ>r 3)

1bm 'Obm, E'Q>rEZEb

-30E, dmer, Zdr

-400703

[aH$ìhar

ñWmda {'iH$V

1993 ghdmMV Am¶H$a A{Y{Z¶', 1961 À¶m

n[a{eîQ>mÀ¶m {Z¶' 37, 38 Am{U 52 (1) (2)

{d.

. embr'ma

Am{U B.

. embr'ma

Am{U BVa, {bbmd

Vm[aI 08.08.2022

¿¶mdm. Or

Am{U Zdeº$s

30.06.2022

àH$m{eV H$aʶmV Ambr. Amanr

hm 73 gZ 2016

Amanr

. 73 gZ 2019 Agm

dmMmdm. BVa

VgmM amhrb.

'm¶m

Am{U

øm 24

2022

.

(

ghr/-

A{YH$mar -II,

(S>rAmaQ>r 3)

: 73E, EgS>rE$ - 3, grßP,

{b{_

_

- 400 096.

: www.igenesys.com

-_

: investor@igenesys.com

: 91 22 4488 4488

_mBb : 91 - 22 - 2829 0603

grAm`EZ : Eb65990E'EM1983nrEbgr029197

O

{b{_

g^m

H$aÊ`mH${aVm

g^m

{X. 14

2022

_

Omar

Vr

(ìhrgr)/

AÝ`

-

_rÝg

_) _

ím{Zdma, {X. 9

2022

. 2.30 dm.

.

_Mr

H$m`Xm,

2013 À`m

{Z`_

^mJYmaH$

_

_ nmR>{dÊ`mV

.

gXa Om{hamV

d

d

Amdí`H$Vm Omar) {d{Z`_Z,

2018 À`m

»mmbrb

A{V{aº$ Vnímrb

H$aÊ`mH${aVm Omar H$aÊ`mV Ambr .

»mmbrb A{V{aº$ ZdrZ

_

. 27/55

. 1 H${aVm

AhdmbmH${aVm

~r À`m Cn

. 4 Mm

_

>

_

dmMmd:

_

Ahdmb E$grE nm`b JS>m,

(Am`grE/ g^mgXËd

. 110424)

H$amdm,

j_

_

_

(Am`~r~rAm`/Amaìhr/

06/2019/11170)

ñnï> _

B{ŠdQ>r

{d{Z`_Z 164,

{d{Z`_Z 166E d

AÝ`

{d{Z`_Z, Oa H$mhr Agë`mg

Am`grS>rAma {d{Z`_Z

5 À`m ^mJ 4

Omarr H$aÊ`mV

_

d

B

H$aÊ`mV

d

Omar

https://www.igenesys.com da

.

_

_

gXa

Agë`mg

_

^mJ

AmYrM

n

H$aÊ`mV

d gXa

_

_

nmhmdr.

gXa

{X

OaZb

d Zdímº$r (_amR>r) _

H$aÊ`mV

www.igenesys.comda

CnbãY

.

d

da CnbãY

d

_

AÝ` Ahdmb

gXa

dm gßbr_

.

ghr/-

{b{_

{dZrV

- {dYr d

g{Md

… 01

2022

{R>H$mÊm : _

(grAm`EZ :Eb24230E'EM1979nrEbgr022059)

:

hmCg'',

n{ü_, _

-400 067.

. : 022-66061000,

: 022-66061200

-_

: investorgrievance@ajantapharma.com,

: www.ajantapharma.com

43 ì¶m

H$r,

("EOrE'') 'm{hVr

i.

A{Y{Z¶', 2013 À¶m

Am{U

2015 ({bñQtJ

gh dmMVm {ZJ' ì¶dhma

(""E'grE'') Am{U

Omar

(EH${ÌV

˦m

EOrE'

H$m'H$mO H$aʶmgmR>r

("ìhrgr')/AXa

{'Ýg

Mr

43 dr EOrE' Vr

4

2022

g.

11.00 dm. ^m.à. .

.

^mJ

A{Y{Z¶',

ii.

2013 ˦m H$b' 103

.

EOrE'Mr

Am{U

{dÎmr¶

2021-22

H$[aVm

Ahdmb

-

nÎmm

Aem

nmR>{dUma

. gXa

www.ajantapharma.com,

Am{U

www.bseindia.com

Am{U

Am{U

www.nseindia.com

Am{U

iii.

(""grS>rEgEb'') ˦m

www.evotingindia.comda

CnbãY

.

AmVm

Z

-

nÎmm

.

E)

à˶j

YmaH$

Am{U

(""AmaQ>rE''),

qbH$

àm.{b.

qbH$

https://linkintime.co.in/

emailreg/email_register.html,da p³bH$$ H$ê$Z Am{U

Am{U ˶m'Yrb

nÎmm

H$ê$ eH$Vm.

~r)

YmaH$

Am¶S>r AÚ¶mdV H$ê$ eH$Vm.

qbH$$

àm.{b.

À¶m qbH$https://linkintime.co.in/emailreg/email_register.html,da p³bH$ H$ê$Z

Am{U ˶m'Yrb

nÎmm

iv.

H$ê$ eH$Vm.

-'VXmZ

'VXmZ

Am{U

gh^mJ

E)

g^mgX

-'VXmZ àUmbr Am{U EOrE' Xaå¶mZ -'VXmZ

EOrE'Mr

H$m'H$mOmda

'VXmZ H$ê$

.

~r)

'VXmZ H$[aVm

-BZ

{d{dY nÜXVr Am{U -

àmá

H$ê$ eH$Vm. ¶mMr

Vnerb

www.ajantapharma.com

grS>rEgEb˦m

www.evotingindia.comda

àmá H$ê$ eH$Vm.

gr)

gh^mJ

.

v.

àmá H$aʶmgmR>r

H$aʶmMr nÜXV.

àmá H$aʶmgmR>r

Q>miʶmH$[aVm

Vnerb AڶmdV H$aʶmgmR>r

YmaH$

Am{U

à˶j

YmaH$

investorgrievance@.ajan-

tapharma.comda Zmd,

Vnerb,

àV Am{U

vi.

ñdmjar

nÌmÀ¶m àVr gh AÚ¶mdV H$aʶmg

.

EOrE'Mr

{Q>nm Am{U

g^mJ,

Am{U

EOrE'

Xaå¶mZ

'VXmZ H$aʶmÀ¶m

nÜXV

vii.

dmMʶmg

.

gXa

E'grE Am{U

'm{hVr Am{U {hVmgmR>r Omar

.

$m_ {b{_

H${aVm

ghr/-

: 01/07/2022

ímmh

{R>H$mU : _

ìhrnr- {dYr d

g{Md

³bm[añgmEbEbnr

5 dm 'Obm,

37-40

400057

EbEbnrAm¶EZ: EEEM-8590

_

I

.

-2

XXI À`m ^mJ

Om{hamV

H$m`Xm, 2013 À`m

374 (~r)

d

{Z`_, 2014 À`m {Z`_ 4(1)

1.

H$r,

H$m`Xm, 2013 À`m

366 À`m Cn-

(2)

À`m

_

H$m`Xm 2013 À`m

XXI À`m ^mJ 1

³bm{gñgm

EbEbnr,

EbEbnr

AmV nU

gXa Vrg {Xdg g'márÀ¶m AmV H$aÊ`mMm

H$aV

.

2.

_

{df`

_ :

[aAb

àH$maÀ¶m {'iH$Vr Am{U

g'm{dï>

{WEQ>a,

a{hdgrV

hmD$g,

ßbmPm,

Ep³P{~eZ

Am{U

hmD$g, ³b~,

é' Am{U

Am{U

EeZMr OmJm,

Am{U H$ÝgëQ>Ýgr

gm{'b, hmD$g{H$qnJ

Am{U BVa

Am{U

àH$maMr ñdV:Mr qH$dm

^mJrXmar

.

3.

_

d

_

nÎmm

nÎmm

5 dm 'Obm,

37-40

400057 VnmgʶmV

.

4.

H$r,

ì`º$rg gXa

Agë`mg

ñdê$nmV

(grAmagr)

(Am`Am`grE),

. 6, 7,

8,

5, Am`E_Q>r _

{Oëhm

(ha`mÊmm), {nZ

-122 050

EH$drg

AmV gXa

gXa

H$aVm

.

1

2022

AJadmb

S>rnrAm¶EZ: 01982024

nX{gÕ ^mJrXma

³bm[añgm

EbEbnr

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Ajanta Pharma Limited published this content on 04 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 July 2022 03:42:02 UTC.